DE60331638D1 - Keratin-netzwerke enthaltende wundverbände für gewebedefekte - Google Patents

Keratin-netzwerke enthaltende wundverbände für gewebedefekte

Info

Publication number: DE60331638D1
Authority: DE; Germany
Prior art keywords: wonder; keratin; associations; tissue diseases; networks containing
Prior art date: 2002-04-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60331638T

Other languages

English (en)

Inventor

Dyke Mark E Van

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Keraplast Technologies Ltd

Original Assignee

Keraplast Technologies Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-10

Filing date

2003-04-10

Publication date

2010-04-22

2002-04-10 Priority claimed from US10/119,477 external-priority patent/US6914126B2/en

2002-04-22 Priority claimed from US10/127,523 external-priority patent/US7001987B2/en

2002-04-26 Priority claimed from US10/133,885 external-priority patent/US6989437B2/en

2003-04-10 Application filed by Keraplast Technologies Ltd filed Critical Keraplast Technologies Ltd

2010-04-22 Application granted granted Critical

2010-04-22 Publication of DE60331638D1 publication Critical patent/DE60331638D1/de

2023-04-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
- A61K38/015—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen from keratin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4741—Keratin; Cytokeratin
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/42—Block-or graft-polymers containing polysiloxane sequences
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/42—Block-or graft-polymers containing polysiloxane sequences
- C08G77/452—Block-or graft-polymers containing polysiloxane sequences containing nitrogen-containing sequences
- C08G77/455—Block-or graft-polymers containing polysiloxane sequences containing nitrogen-containing sequences containing polyamide, polyesteramide or polyimide sequences
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Polymers & Plastics (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Materials Engineering (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)
Materials For Medical Uses (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Colloid Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)

DE60331638T 2002-04-10 2003-04-10 Keratin-netzwerke enthaltende wundverbände für gewebedefekte Expired - Fee Related DE60331638D1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US10/119,477 US6914126B2 (en)	2002-04-10	2002-04-10	Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks
US10/127,523 US7001987B2 (en)	2002-04-22	2002-04-22	Hydrogel with controllable mechanical, chemical, and biological properties and method for making same
US10/133,885 US6989437B2 (en)	2002-04-10	2002-04-26	Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US39395802P	2002-07-05	2002-07-05
PCT/US2003/011364 WO2003086491A2 (en)	2002-04-10	2003-04-10	Tissue defect dressings comprising a keratin network

Publications (1)

Publication Number	Publication Date
DE60331638D1 true DE60331638D1 (de)	2010-04-22

Family

ID=29255535

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60331638T Expired - Fee Related DE60331638D1 (de)	2002-04-10	2003-04-10	Keratin-netzwerke enthaltende wundverbände für gewebedefekte

Country Status (10)

Country	Link
EP (2)	EP1494728B1 (de)
JP (2)	JP2005528938A (de)
AT (1)	ATE460188T1 (de)
AU (5)	AU2003221916A1 (de)
CA (2)	CA2482262A1 (de)
DE (1)	DE60331638D1 (de)
DK (1)	DK1495048T3 (de)
ES (1)	ES2460926T3 (de)
NZ (2)	NZ536159A (de)
WO (4)	WO2003087195A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4662948B2 (ja) *	2003-12-19	2011-03-30	ケラテクリミテッド	ケラチンを含む創傷ケア製品
BRPI0513954A (pt) *	2004-07-30	2008-05-20	Matsushita Electric Ind Co Ltd	transmissor sem fio e método de transmissão sem fio
US7439012B2 (en)	2004-08-17	2008-10-21	Wake Forest University Health Sciences	Ambient stored blood plasma expanders containing keratose
US8920827B2 (en)	2005-10-21	2014-12-30	Wake Forest University Health Sciences	Keratin bioceramic compositions
US7892573B2 (en)	2006-02-10	2011-02-22	Wake Forest University Health Sciences	Nerve regeneration employing keratin biomaterials
US8273702B2 (en)	2006-02-17	2012-09-25	Wake Forest University Health Sciences	Wound healing compositions containing keratin biomaterials
WO2007098053A2 (en)	2006-02-17	2007-08-30	Wake Forest University Health Sciences	Coatings and biomedical implants formed from keratin biomaterials
US8101717B2 (en)	2006-11-13	2012-01-24	The University Of Sydney	Use of tropoelastin for repair or restoration of tissue
GB0622694D0 (en) *	2006-11-14	2006-12-27	Serentis Ltd	Use of opioid compounds in wound healing
JP5868592B2 (ja) *	2007-04-17	2016-02-24	ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ	ケラチンバイオマテリアルを含有する創傷治癒組成物
US9068162B2 (en)	2007-08-17	2015-06-30	Wake Forest University Health Sciences	Keratin biomaterials for cell culture and methods of use
WO2010132673A1 (en)	2009-05-13	2010-11-18	Keraplast Technologies, Ltd.	Biopolymer materials
CN102458795B (zh)	2009-06-22	2014-09-03	博里利斯股份公司	耐二氧化氯的聚乙烯管，其制备和用途
WO2011109808A1 (en)	2010-03-05	2011-09-09	Wake Forest University Health Sciences	Controlled delivery system
WO2011112575A1 (en)	2010-03-08	2011-09-15	Wake Forest University Health Sciences	Keratin biomaterials for treatment of ischemia
CA2818166C (en)	2010-11-17	2019-04-30	Wake Forest University Health Sciences	Keratin compositions for treatment of bone deficiency or injury
US9700631B2 (en)	2011-08-17	2017-07-11	KeraNetics, LLC	Low protein percentage gelling compositions
WO2013025928A2 (en)	2011-08-17	2013-02-21	Keranetics Llc	Methods for extracting keratin proteins
US9827245B2 (en)	2013-03-15	2017-11-28	KeraNetics, LLC	Keratin compositions comprising halofuginone
US9783905B2 (en) *	2014-12-30	2017-10-10	Rohm and Haas Electronic Mateirals LLC	Reaction products of amino acids and epoxies
CN105126148B (zh) *	2015-08-03	2018-03-23	广东泰宝医疗科技股份有限公司	一种可视银释放敷料及其制备方法
CN114681673B (zh) *	2020-12-31	2023-05-23	杭州启明医疗器械股份有限公司	抗折痕的脱水交联生物材料及其制备方法和应用
US20250090719A1 (en) *	2021-07-30	2025-03-20	Regents Of The University Of Minnesota	Biomaterials for embolization and drug delivery

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL274938A (de) *	1961-02-22
BE758986A (fr) *	1969-11-18	1971-04-30	Iws Nominee Co Ltd	Procede de foulage de tissus textiles
DE2364525A1 (de) *	1973-12-24	1975-07-03	Henkel & Cie Gmbh	Neue n-polyhydroxyalkyl-aminosaeuren, deren herstellung, sowie diese enthaltende hautpflege- und hautschutzmittel
EP0097907A3 (de) *	1982-06-25	1985-01-09	Flow General, Inc.	Mikroträger für Zellkultur
US4474694A (en) *	1982-11-08	1984-10-02	Ralston Purina Company	Modified protein adhesive binder and method of producing
JPS59155248A (ja) *	1983-02-22	1984-09-04	テルモ株式会社	被覆膜およびその製法
US4795629A (en) *	1987-07-06	1989-01-03	Chesebrough-Pond's Inc.	Crosslinking of hair thiols using cystamine
JPH0725778B2 (ja) *	1987-10-21	1995-03-22	花王株式会社	リン酸エステル、その製造法およびそれを含有する洗浄剤組成物
GB9123251D0 (en) *	1991-11-01	1991-12-18	Croda Int Plc	Protein-silicone copolymers
FR2692582B1 (fr) *	1992-06-18	1998-09-18	Flamel Tech Sa	Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
US5300285A (en) *	1992-10-13	1994-04-05	Dow Corning Corporation	Permanent waving with silicones
US5505952A (en) *	1994-04-19	1996-04-09	United States Surgical Corporation	Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
US6214331B1 (en) *	1995-06-06	2001-04-10	C. R. Bard, Inc.	Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US6352699B1 (en) *	1997-04-04	2002-03-05	L'oreal	Cosmetic or dermatological composition forming, on a keratin substrate, a film in cross-linked hybrid material
DE69821548T2 (de) *	1997-05-29	2004-12-30	Rohm And Haas Co.	Vernetzte Polyaminsäure und deren Verfahren zur Herstellung
US6110487A (en) *	1997-11-26	2000-08-29	Keraplast Technologies Ltd.	Method of making porous keratin scaffolds and products of same
US5932552A (en) *	1997-11-26	1999-08-03	Keraplast Technologies Ltd.	Keratin-based hydrogel for biomedical applications and method of production
US5948432A (en) *	1997-11-26	1999-09-07	Keraplast Technologies Ltd.	Keratin-based sheet material for biomedical applications and method of production
US7662409B2 (en) *	1998-09-25	2010-02-16	Gel-Del Technologies, Inc.	Protein matrix materials, devices and methods of making and using thereof
US6371984B1 (en) *	1999-09-13	2002-04-16	Keraplast Technologies, Ltd.	Implantable prosthetic or tissue expanding device
DE60228573D1 (de) *	2001-05-30	2008-10-09	Chisso Corp	Vernetztes elastin und verfahren zu deren herstellung
US6989437B2 (en) *	2002-04-10	2006-01-24	Keraplast Technologies, Ltd.	Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks

2003
- 2003-04-10 NZ NZ536159A patent/NZ536159A/en not_active IP Right Cessation
- 2003-04-10 AU AU2003221916A patent/AU2003221916A1/en not_active Abandoned
- 2003-04-10 JP JP2003583502A patent/JP2005528938A/ja active Pending
- 2003-04-10 JP JP2003584148A patent/JP2006508027A/ja active Pending
- 2003-04-10 AU AU2003234721A patent/AU2003234721A1/en not_active Abandoned
- 2003-04-10 WO PCT/US2003/011102 patent/WO2003087195A2/en active Application Filing
- 2003-04-10 WO PCT/US2003/011101 patent/WO2003087197A1/en not_active Application Discontinuation
- 2003-04-10 CA CA002482262A patent/CA2482262A1/en not_active Abandoned
- 2003-04-10 WO PCT/US2003/011247 patent/WO2003087156A2/en not_active Application Discontinuation
- 2003-04-10 AT AT03718375T patent/ATE460188T1/de not_active IP Right Cessation
- 2003-04-10 AU AU2003221870A patent/AU2003221870B2/en not_active Ceased
- 2003-04-10 DE DE60331638T patent/DE60331638D1/de not_active Expired - Fee Related
- 2003-04-10 CA CA002482215A patent/CA2482215A1/en not_active Abandoned
- 2003-04-10 ES ES03718328.2T patent/ES2460926T3/es not_active Expired - Lifetime
- 2003-04-10 DK DK03718328.2T patent/DK1495048T3/da active
- 2003-04-10 EP EP03718375A patent/EP1494728B1/de not_active Expired - Lifetime
- 2003-04-10 EP EP03718328.2A patent/EP1495048B1/de not_active Expired - Lifetime
- 2003-04-10 WO PCT/US2003/011364 patent/WO2003086491A2/en active Application Filing
- 2003-04-10 AU AU2003224926A patent/AU2003224926A1/en not_active Abandoned
- 2003-04-10 NZ NZ536158A patent/NZ536158A/en not_active IP Right Cessation
2009
- 2009-02-25 AU AU2009200774A patent/AU2009200774A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003086491A2 (en)	2003-10-23
AU2003221916A1 (en)	2003-10-27
WO2003087156A3 (en)	2004-09-02
DK1495048T3 (da)	2014-05-05
EP1495048A2 (de)	2005-01-12
WO2003087195A3 (en)	2004-07-15
AU2003234721A1 (en)	2003-10-27
CA2482215A1 (en)	2003-10-23
WO2003086491A3 (en)	2004-02-26
EP1494728B1 (de)	2010-03-10
AU2003221870A1 (en)	2003-10-27
WO2003087195A2 (en)	2003-10-23
NZ536159A (en)	2006-05-26
ES2460926T3 (es)	2014-05-16
EP1494728A2 (de)	2005-01-12
CA2482262A1 (en)	2003-10-23
WO2003087156A2 (en)	2003-10-23
AU2003224926A1 (en)	2003-10-27
ATE460188T1 (de)	2010-03-15
AU2003234721A8 (en)	2003-10-27
JP2005528938A (ja)	2005-09-29
WO2003087197A1 (en)	2003-10-23
AU2003221870B2 (en)	2009-06-04
EP1495048B1 (de)	2014-03-05
WO2003086491B1 (en)	2004-04-01
AU2009200774A1 (en)	2009-03-19
JP2006508027A (ja)	2006-03-09
NZ536158A (en)	2009-12-24

Publication	Publication Date	Title
DE60331638D1 (de)	2010-04-22	Keratin-netzwerke enthaltende wundverbände für gewebedefekte
CY1107628T1 (el)	2013-04-18	Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
CY1113243T1 (el)	2016-04-13	Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
DE60023043T2 (de)	2006-06-14	(S,S)-Reboxetin zur Behandlung von Inkontinenz
EA200400481A1 (ru)	2004-10-28	Применение флибансерина для лечения половых расстройств
BRPI0414593A (pt)	2006-11-07	derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
BRPI0418245A (pt)	2007-04-17	nitróxi-derivados de prostaglandina
ATE402663T1 (de)	2008-08-15	Flächiges implantat
WO2004009774A3 (en)	2004-04-15	Protein conjugates with a water-soluble biocompatible, biogradable polymer
CY1108747T1 (el)	2014-04-09	Παρασκευες ενος σουλφινυλο ακεταμιδιου
ECSP044862A (es)	2004-03-23	Pirenzepine ophthalmic gel
ATE427127T1 (de)	2009-04-15	Bioaktive beschichtung fur medizinische vorrichtung mit keratin
SE0003537L (sv)	2002-04-03	Hudvänligt lim
ATE318607T1 (de)	2006-03-15	Heparin-haltiges ophthalmikum
WO2001034647A3 (en)	2001-12-06	Animal collagens and gelatins
CY1108599T1 (el)	2014-04-09	Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
ITRM20020529A1 (it)	2004-04-19	Polimeri sterilizzanti, processo di loro preparazione ed uso.
AU2002221908A1 (en)	2002-06-18	Novel use of protein hydrolysates
AR026708A1 (es)	2003-02-26	Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma
CY1105317T1 (el)	2010-03-03	Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el)	2009-11-04	Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1107158T1 (el)	2012-10-24	Νεα παραγωγα της ισοκινολινης, η μεθοδος παρασκευης τους και η χρηση τους για τη θεραπεια των διαταραχων του μελατονινεργικου συστηματος
ATE454112T1 (de)	2010-01-15	Brustprothese
AR033270A1 (es)	2003-12-10	Dispositivo para la osteosintesis
BR0110490B1 (pt)	2012-07-24	agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.

Legal Events

Date	Code	Title	Description
2011-02-17	8339	Ceased/non-payment of the annual fee